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Abstract
Background: The recent Canadian lawsuit on patent infringement, filed by the Children’s Hospital of Eastern
Ontario (CHEO), has engendered a significant public debate on whether patenting genes should be legal in
Canada. In part, this public debate has involved the use of social networking sites, such as Twitter. This case
provides an opportunity to examine how Twitter was used in the context of this gene patent controversy.
Methods: We collected 310 English-language tweets that contained the keyword “gene patents” by using
TOPSY.com and Twitter’s built-in search engine. A content analysis of the messages was conducted to establish the
users’ perspectives on both CHEO’s court challenge and the broader controversy over the patenting of human
DNA. More specifically, we analyzed the users’ demographics, geographic locations, and attitudes toward the CHEO
position on gene patents and the patentability of human genes in principle.
Results: Our analysis has shown that messages tweeted by news media and health care organizations were re-tweeted
most frequently in Twitter discussions regarding both the CHEO patent infringement lawsuit and gene patents in general.
34.8 % of tweets were supportive of CHEO, with 52.8 % of the supportive tweets suggesting that gene patents
contravene patients’ rights to health care access. 17.6 % of the supportive tweets cited ethical and social concerns against
gene patents. Nearly 40 % of tweets clearly expressed that human genes should not be patentable, and there were no
tweets that presented perspectives favourable toward the patenting of human genes.
Conclusion: Access to healthcare and the use of genetic testing were the most important concerns raised by Twitter
users in the context of the CHEO case. Our analysis of tweets reveals an expectation that the CHEO lawsuit will provide an
opportunity to clear the confusion on gene patents by establishing a legal precedent on the patentability of human
genes in Canada. In general, there were no tweets arguing in favour of gene patents. Given the emerging role of social
media in framing the public dialogue on these issues, this sentiment could potentially have an impact on the nature and
tone of the Canadian policy debate.
Background
With over 300,000,000 active users, Twitter has
emerged as an important source of health-related infor-
mation for both the general public and the research
community [1, 2]. There is a growing body of scholar-
ship that suggests that Twitter can have a significant
impact on public perceptions as well as the framing of
public policy issues and debates [3–7]. In this regard,
opinions shared on Twitter can both reflect and shape
public understandings and public discourse [8, 9]. Fur-
thermore, Twitter is an important resource for research
on public attitudes towards biomedicine and has the
potential to facilitate knowledge exchange and public
engagement with issues relating to health and illness
[10]. To date, there has been no analysis of Twitter in
the context of gene patents, one of the most conten-
tious and longstanding policy issues in this area of
research.
Canada is a jurisdiction where there has yet to be a
high level of judicial scrutiny into the validity of gene
patents [11]. Naturally occurring human genes are no
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longer patent-eligible in the United States after the
Supreme Court’s decision in Myriad [12], but they are
currently allowed under the existing Canadian patent
law [13]. On November 3, 2014, a highly publicized
lawsuit was launched in Canada by CHEO to invalidate
patents for five genes associated with Long QT Syn-
drome (LQTS), a rare disorder of the heart’s electrical
activity that may cause sudden, uncontrollable and dan-
gerous arrhythmias [14, 15]. The LQTS gene patent
holders requested that CHEO cease to conduct genetic
testing for LQTS, and that patients’ blood samples be
sent for analysis to licensed labs in the US. Currently,
the cost of genetic testing in the US licensed labs is
more than $4000 US dollars, with costs being half the
price in Canadian hospitals [16, 17]. Given their poten-
tial impact on access to health care service within the
Canadian system, news media, patient groups, and aca-
demics have long debated whether gene patents should
be allowed in Canada [18, 19].
The CHEO case is the first legal action in Canada to
challenge the patentability of human genes. Given its
important policy implications, as well as the controver-
sial nature of gene patenting more generally [20], the
lawsuit has provided a good opportunity to examine
how Twitter users represent their attitudes toward the
CHEO lawsuit and gene patenting issues generally. In
this paper, we analyze the content of tweets on both the
CHEO case and gene patents more broadly, which were
posted in the month immediately following news of
CHEO having filed the lawsuit. We explore the Twitter
users’ perspectives on the CHEO lawsuit and its societal
implications, as well as their overall attitudes toward the
issue of gene patents.
Methods
We extracted the study sample using a combination of
Twitter’s built-in search engine and TOPSY.com, a social
search and analytics company that is partnered with
Twitter, and which enables real-time searches for Twit-
ter content. We collected all relevant tweets by using the
keyword “gene patent”, and we excluded messages that
did not mention the CHEO gene patent lawsuit or gene
patents in general. The final dataset consisted of 310
English-language tweets that tweeted from November 3
— the date of the CHEO lawsuit was announced to
December 3, 2014. We conducted a quantitative content
analysis of the tweets to establish how CHEO’s court
challenge and the broader controversy over the patent-
ing of human DNA were represented. Tweets were
coded for: 1) date of tweet; 2) sender information; 3)
mentions of CHEO; 3) positive or negative attitude to-
wards the CHEO lawsuit; and 4) the reasons for support-
ing or opposing the lawsuit.
Since content analysis is considered subjective, we
asked an independent coder to code approximately 10 %
of the tweets in our dataset (n = 34). An inter-coder reli-
ability assessment was conducted using Cohen’ Kappa
(k), which generated k scores on different coding cat-
egories in the range of 0.735-1.000, indicating substantial
or almost perfect agreement based on the Landis &
Koch’s benchmark for interpreting kappa [21].
Results
Twitter users reacted quickly to the news that the CHEO
had launched a legal action over gene patents. The peak
(n = 126) occurred on 3 November 2014, the first day that
the hospital announced the gene patent lawsuit. The num-
ber of tweets decreased (n = 92) on 4 November 2014, and
then dropped to less than seven tweets daily from Novem-
ber 7 to 24 (See Fig. 1). In terms of the geographic origin
of the tweets, most senders (n = 166) were from Canada,
with a comparatively small number of tweets (n = 29)
posted by Twitter users in the United States. Over 60 % of
the tweets (n = 191) were sent out by individuals. Mem-
bers of the general public (i.e., Twitter users that did not
specify their occupations or affiliations) were the majority,
making up 32.9 % of the message senders (n = 102),
whereas academics accounted for 15.8 % (n = 49) of the
senders. For tweets that were sent by organizations,
the following distribution was observed: advocacy and
non-profit groups, 33.6 % (n = 40); news media, 31.9 %
(n = 38); and health institutions, 17.6 % (n = 21)
(Table 1).
We found that the most frequently re-tweeted mes-
sages (see Table 2) were headlines of news reports or ar-
ticles published on news media websites and the
majority of these tweets had incorporated web links to
the news reports or articles. For example, the most
popular re-tweet (n = 36), “How a gene-patent test case
will help both patients and inventors” was the title of a
review article published in The Globe and Mail. This
article was authored by three Canadian university pro-
fessors, including Richard Gold, a law professor at
Fig. 1 Number of tweets from 3 November, 2014 to 3
December, 2014
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McGill University, who was providing pro bono legal
services to Gilbert’s LLP, the law firm representing the
CHEO in the Long QT gene patent lawsuit [22]. Simi-
larly, other commonly re-tweeted messages, such as:
“Ontario hospital launches lawsuit against owners of
gene patent;” “No one should be able to patent human
DNA;” and “Gene patent lawsuit aims to clear up confu-
sion in Canada” are all news headlines that appeared on
major news media websites.
There were 83.5 % tweets (n = 259) that mentioned the
CHEO’s gene patent lawsuit. Our data showed that 34.8 %
of tweets (n = 108) were supportive of CHEO, whereas the
overall tone of 48.7 % of tweets (n = 151) was neutral or
descriptive. When all tweets were taken into consider-
ation, including those that did not mention the CHEO
case, 38.7 % (n = 120) opposed the patenting of genes and
the remaining tweets (n = 190) were neutral in tone. It is
worth noting that no tweet explicitly supported gene pat-
ents. Twitter users’ most commonly stated reason for sup-
porting CHEO was the need to protect patients’ access to
diagnostics and health care, as indicated by the variable –
18.4 % (n = 57). Other two frequently stated reasons for
supporting the hospital’s decision to file the lawsuit
included: 1) claims that it’s morally wrong to own or patent
human genes (6.1 % (n = 19)); and 2) claims that human
DNA is not patentable (4.8 % (n = 15)) (see Table 3).
Discussion
Our research indicates that most frequently re-
tweeted messages were tweets posted by news media
organizations (e.g., CBC Health New, CTV News, The
Global and Mail) and health care institutions (e.g.,
CHEO). While tweeting news on CHEO’s lawsuit was
the major characteristic of user activity, arguments
against the patenting of human genes were a common
theme (e.g., claims that gene patents will hamper pa-
tients’ access to diagnostics). Links to news media sites
that discussed gene patent controversies were widely
shared and included in many tweets. Given the exist-
ing literature on framing and the impact of social
media, these findings hint at the possible impact of
Twitter on the public’ perceptions of the gene patents
controversy [23].
Although 61 % of tweets did not explicitly express the
user’s personal attitudes toward gene patents, our ana-
lysis has shown that nearly 40 % of users did argue
against gene patenting and that there were no tweets
that explicitly opposed CHEO’s decision to challenge
LQTS patents in court. In fact, 34.8 % tweets were sup-
portive of the hospital. Most significant, there were no
tweets arguing in favour of gene patents in general.
These findings are consistent with previous studies that
have shown negative public attitudes towards biotech-
nology patents [23–25]. Although Twitter posts are lim-
ited to 140 characters, there were some nuanced
perspectives shared on Twitter when debating whether
human genes should be patented. For example, the
Table 1 Demographics of the users
Senders Number of sources Percentage
Individuals 191 61.6(%)
Members of the public 102 53.4
Academics 49 25.7
Journalists 14 7.3
Clinical practitioners 12 6.3
IP lawyers 12 6.3
Industry representatives 2 1.0
Organizations 119 38.4(%)
Advocacy/non-profit groups 40 33.6
News media 38 32.0
Health institutions 21 17.6
Law firms 14 11.8
Academic institutions 6 5.0
Table 2 Content of frequently re-tweeted messages
Content of the tweet Re-tweeted times
“How a gene-patent test case will help both
patients and inventors”
36
“Ontario hospital launches lawsuit against
owners of gene patent”
28
“No one should be able to patent human DNA” 19
“Gene patent lawsuit aims to clear up confusion
in Canada”
15
“CHEO launches legal challenge of gene patent
in order to protect patient care”
11
Table 3 Reasons for supporting CHEO
Arguments supporting the CHEO hospital Number of
tweets
• Protect patient care (e.g., access to diagnostics) 57
• It’s morally wrong to own/patent genes 19
• Lawsuit can help clear confusion on gene patents 15
• Saving $200,000 in health care cost annually 1
• US gene test monopoly 1
Arguments against gene patents in principle
• Negative impact on patient care 25
• It’s morally wrong to own gene patents, or patient
sharing of life-saving information
23
• Discovery of genes is not invention 13
• Gene patents invalidated in the US 3
• Patenting human genes is the same as owing
humans
2
• Genetic test monopoly 1
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frequently re-tweeted message, “How a gene-patent case
will help both patents and inventors”, incorporated a
link to a review article that provided an analysis that
argued that the existing Canadian gene patent system
restricts access to diagnostics and data, which will nega-
tively impact both patient health care and the develop-
ment of genomics-based biomedical research [26]. Some
tweets suggested that the CHEO case provides an oppor-
tunity to clarify the existing confusion surrounding gene
patents in Canada.
With regard to rationales that were provided to
support a position against patenting genes, several le-
galistic arguments, such as “it should not be legal to
patent gene mutations”, and the “discovery of genes is
not an invention”, were presented, but they were not
significant themes. The US Supreme Court’s ruling in
Myriad was also mentioned by some Twitter users
[27]. The most common argument for opposing gene
patents involved concerns associated with access to
health care. Many Twitter users seemed worried about
the possibility of private companies’ using patents to
limit patients’ access to patient care, with more spe-
cific concerns focusing on how patents may affect the
rare disease community, such as patients with LQTS.
The findings also reveal some users’ ethical concerns
about the patenting of human genetic materials (e.g.,
that patenting human gene is morally unacceptable
and that naturally occurring genes should not be pa-
tentable). While we can only speculate about reasons
that are driving Twitter users’ comments, studies have
shown that media portrayals of gene patenting debates
are relevant [24] and surveys have found a general
negative attitude toward the idea of patenting human
genes [28]. Furthermore, there is an ongoing public
debate about how best to ensure access to expensive
treatments for rare diseases [29].
Conclusion
Although the CHEO news story did not become a viral
global news story on Twitter, it did receive immediate
attention by Twitter users, especially in Canada. Our
content analysis of Twitter users’ responses to the break-
ing news indicates that individuals who have reserva-
tions about gene patents do share those sentiments on
Twitter. While many tweets focused on spreading the
message about the pending lawsuit, users have also artic-
ulated specific reasons for opposing the patenting of hu-
man genes and have speculated about the potential
impact of the lawsuit on patients and IP rights holders
in Canada. In general, Twitter users did not post tweets
in support of gene patents. Given the emerging role of
social media in the framing of public dialogue, this senti-
ment could have an impact on the nature and tone of
the Canadian policy debate.
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